This study will test to see if metformin is safe and if it is effective compared to placebo in adult Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients with beginning stages of chronic kidney disease. We will also measure its effect on progression of kidney disease as reflected in the kidney size and the kidney function, along with its effect on kidney pain and quality of life.
| Study Type : |
Interventional (Clinical Trial) |
| Estimated Enrollment : |
96 participants |
| Allocation: |
Randomized |
| Intervention Model: |
Parallel Assignment |
| Masking: |
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: |
Treatment |
| Official Title: |
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease |
| Study Start Date : |
May 2016 |
| Estimated Primary Completion Date : |
June 2020 |
| Estimated Study Completion Date : |
September 2020 |
Contacts
For enrollment please visit www.clinicaltrials.gov.
